Technique and feasibility of a dual staining method for estrogen receptors and AgNORs

Similar documents
Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

Conference Paper Programmed Cell Death Induced by Modulated Electrohyperthermia

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach

Supplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma

Value of Argyrophilic Nucleolar Organizer regions in Benign, Premalignant, and Malignant Lesions of Cervix Uteri

Conference Paper Oncothermia Basic Research at In Vivo Level: The First Results in Japan

AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage,

Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers

Dr. dr. Primariadewi R, SpPA(K)

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

AgNOR and breast cancer. A study by image analysis

DIAGNOSTIC VALUE OF SILVER-STAINED NUCLEOLAR ORGANIZER REGIONS IN OSTEOSARCOMA, FIBROUS DYSPLASIA AND OSSIFYING FIBROMA OF THE JAWS

Single and Multiplex Immunohistochemistry

Histological Value of Duodenal Biopsies

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Case Study: The Surgical Management of Angiokeratoma Resulting from Radiotherapy for Penile Cancer

Bilateral Segmental Testicular Infarction

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

R. F. Falkenstern-Ge, 1 S. Bode-Erdmann, 2 G. Ott, 2 M. Wohlleber, 1 and M. Kohlhäufl Introduction. 2. Histology

Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California

General Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:

Brief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies

Immunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy

Solitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer

Estrogen receptor (ER)

Breast Cancer Interpretation Guide

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

Citation Acta medica Nagasakiensia. 1993, 38

Case Report A Case of Cystic Basal Cell Carcinoma Which Shows a Homogenous Blue/Black Area under Dermatoscopy

Mandana Moosavi 1 and Stuart Kreisman Background

P16 GENE EXPRESSION IN OVARIAN EPITHELIAL CYSTADENOCARCINOMA

The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis

Clinical utility of cancer biomarkers assessed by virtual microscopy

Research Article Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer

Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma

Case Report Multiple Giant Cell Tumors of Tendon Sheath Found within a Single Digit of a 9-Year-Old

Immunohistochemistry in Breast Pathology- Brief Overview of the Technique and Applications in Breast Pathology

Research Article Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions

Gastric Signet-Ring Cell Carcinoma: Unilateral Lower Extremity Lymphoedema as the Presenting Feature

Case Report Three-Dimensional Dual-Energy Computed Tomography for Enhancing Stone/Stent Contrasting and Stone Visualization in Urolithiasis

WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids

Priti Lal, MD, 1 Paulo A. Salazar, 1 Clifford A. Hudis, MD, 2 Marc Ladanyi, MD, 1 and Beiyun Chen, MD, PhD 1. Abstract

Product Introduction. Product Codes: HCL029, HCL030 and HCL031. Issue

LIST OF ORGANS FOR HISTOPATHOLOGICAL ANALYSIS:!! Neural!!!!!!Respiratory:! Brain : Cerebrum,!!! Lungs and trachea! Olfactory, Cerebellum!!!!Other:!

Case Report Two Cases of Small Cell Cancer of the Maxillary Sinus Treated with Cisplatin plus Irinotecan and Radiotherapy

Research Article A Structured Assessment to Decrease the Amount of Inconclusive Endometrial Biopsies in Women with Postmenopausal Bleeding

Case Report Metastatic Malignant Melanoma of Parotid Gland with a Regressed Primary Tumor

Int J Clin Exp Pathol 2017;10(3): /ISSN: /IJCEP

Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia

Digital Pathology - moving on after implementation. Catarina Eloy, MD, PhD

Citation Acta medica Nagasakiensia. 1994, 39

The following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details.

Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-

Quality Assurance and Quality Control in the Pathology Dept.

SMH (Myosin, smooth muscle heavy chain)

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

Case Report Clear Cell Basal Cell Carcinoma

Image analysis in IHC overview, considerations and applications

Case Report Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection

Case Report Primary Neuroendocrine Carcinoma of Ocular Adnexa

Conference Paper Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized Medicine

Contributions to Anatomic Pathology, over the years

CIHRT Exhibit P-1830 Page 1

Case Report Intracranial Capillary Hemangioma in the Posterior Fossa of an Adult Male

Breast cancer: Antibody selection, protocol optimzation controls and EQA

Case Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma of Thyroid

Quality assurance and quality control in pathology in breast disease centers

SECONDARIES: A PRELIMINARY REPORT

Comparison and Evaluation of Mitotic Figures in Oral Epithelial Dysplasia using Crystal Violet and Feulgen Stain

Correspondence should be addressed to Alicia McMaster;

Supplementary Appendix

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.

Correspondence should be addressed to Taha Numan Yıkılmaz;

Kobe University Repository : Kernel

Pepsin Solution ready-to-use

Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women

NordiQC External Quality Assurance in Immunohistochemistry

Cells and viruses. Human isolates (A/Kawasaki/173/01 [H1N1], A/Yokohama/2057/03 [H3N2],

Assessment Run GATA3

Assessment Run B HER-2 IHC. HER-2/chr17 ratio**

Clinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System

Minimum Formalin Fixation Time for Consistent Estrogen Receptor Immunohistochemical Staining of Invasive Breast Carcinoma

Research Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario

COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME

Case Report Optic Disk Pit with Sudden Central Visual Field Scotoma

Study of Melanin Bleaching After Immunohistochemistry of Melanin-containing Tissues. Hongwu Shen, MD and Wenqiao Wu, MD

Synchronous Hepatic Cryotherapy and Resection

Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy

Aspects of quality in breast pathology. Andrew Lee Nottingham University Hospitals

IT S ABOUT TIME. IQFISH pharmdx Interpretation Guide THREEHOURSTHIRTYMINUTES. HER2 IQFISH pharmdxtm. TOP2A IQFISH pharmdxtm

ALAEZI CM 1 *, ADISA JO 2, OKOROCHI EC 3 and OKECHI OO 4

Transcription:

151 Technical note Technique and feasibility of a dual staining method for estrogen receptors and AgNORs Lukas Günther a, and Peter Hufnagl b a Department of Surgery, University of Heidelberg, Heidelberg, Germany b Institute of Pathology, Charité Hospital, Humboldt-University Berlin, Germany Received 2 November 1999 Accepted 11 September 2000 A new staining method for dual demonstration of Estrogen receptors (ER) and argyrophilc Nucleolus-Organizer Regions (AgNORs) was developed. To rule out possible reciprocal effects, serial slides of 10 invasive ductale breast cancers were stained with either the single staining method or the simultaneous ER/AgNOR-staining method and investigated comparatively. By measuring the slides with the image analysis system AMBA, reciprocal effects could be excluded. It was proven that dual staining of both markers results in a reproducible and specific staining result. We concluded that it is justified to measure AgNORs in immunohistochemically stained cells. Keywords: AgNORs, estrogen receptors, immunohistochemistry, breast cancer, dual staining, reproducibility 1. Introduction The combination of immunohistochemical methods and other staining techniques for measuring different malignancy-associated parameters in the same cell is a new focus of pathohistological research. For combined cellular investigation of AgNORs and estrogen receptors, a special staining procedure for dual demonstration of AgNORs and ER in the same histological slide is required. Since reciprocal influences cannot be excluded en passant, the reproducibility of a dual * Corresponding author: Lukas Günther, M.D., Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Ave., #370, Boston, MA 02215, USA. staining technique has to be proved. This study investigates if the simultaneous staining effects the staining and measuring results (percentage of ER-positive cells; AgNOR number and area). The central question is whether AgNOR measurements in immunhistochemically stained cells are reproducible and comparable to measurements in single stained specimen. 2. Material and methods Tissue of 10 invasive ductal breast cancers was used. Five cases were negative for estrogen receptors, the other 5 were ER-positive. The cancer tissue was routinely fixed in formalin 10% and embedded in paraffin. Slides of 3 µm thickness were produced. For dual demonstration of estrogen receptors and AgNORs, the slides were firstly stained for ER and in a second step for AgNORs. 2.1. Estrogen receptor staining After deparaffinisation (30 min) and hydration in graded alcohols slides were autoclaved for 5 min in citric acid buffer (ph = 6.0). Afterwards the slides were incubated with the primary antibody (estrogen receptor monoclonal antibody Nr. 1344 by Immunotech; dilution 1 : 50). DAKO LSAB2 R Kit K 0674 (biotinylated secondary antibody and Streptavidine/Alkaline Phosphatase) was used as detection system and SIGMA FAST R Fast Red TR/Naphtol AS-MX as chromogene. Since paraffin residues increase non-specific background staining, a thorough cleaning of the slides is necessary. The ph level of the Citric acid buffer has to be exactly 6.0 because even small deviations affect the staining result. The slides must not dry up during the preparation and have to be incubated in a humid chamber at 37 C. The antibody solution has always to exceed the section edges. Otherwise, local drying-up effects ( edge effects ) causes a higher level of background staining. Analytical Cellular Pathology 20 (2000) 151 154 ISSN 0921-8912 / $8.00 2000, IOS Press. All rights reserved

152 L. Günther and P. Hufnagl / Dual staining of estrogen receptors and AgNORs 2.2. AgNOR staining To maintain a reproducible staining result standardization of the staining and measuring process according to the guidelines of the International Committee on AgNOR-quantification [1] was guaranteed. After preparing the staining solution (5 g AgNO 3 /20 ml aqua bidest with 200 mg gelatin/10 ml 1% HCOOH), the slides were incubated at room temperature in a dark environment for exactly 30 min. 2.3. Image analysis and measuring procedure The image analysis system AMBA which was developed at the Laboratory for Automated Image Analysis at the Institute of Pathology, University Hospital Charité, Berlin, was used for the reproducibility investigations. To rule out possible reciprocal staining effects, 3 serial slides of 10 invasive ductal breast carcinomas (5 ER-positive and 5 ER-negative cases) were stained for ER or AgNOR or ER/AgNOR and investigated comparatively. Firstly, one slide of each case was stained with the AgNOR method only. Another slide was stained for ER and AgNORs. A set of 200 nuclei per slide was measured by means of the program norcolor (objective: 40 ; numerical aperture: 0.7). It was measured in corresponding image sections. AgNOR number per nucleus (NORNB) and total AgNOR area per nucleus (NORAREA) were evaluated. Secondly, one slide was stained for ER, a different one stained for ER/AgNORs. For quantification of the ER staining result, the number of ER-positive nuclei per image section was counted in a set of 6 corresponding image sections (magnification 200; objective: 40 ; numerical aperture: 0.7). Counting of all marked cells per image section (mean = 355 cells/image section) was done semiautomatically by means of a special counting program that offers interactive object counting within microscopic images. 3. Results ER positive nuclei were stained red. In contrast ER-negative nuclei appear light yellow. The yellowish color is an artificial result of the silver staining technique. Even though no counterstaining was performed, ER-negative cells are visible and measurable. In ER- Fig. 1. Cells of invasive ductal breast cancer (G2). Dual staining for ER and AgNORs (objective 40 ). positive as well as in ER-negative nuclei, AgNORs are visible as black-brownish dot-like structures (Fig. 1). When the ER staining is carried out firstly a severe loss of ER-staining sensitivity was noticed. When the ER staining is done after AgNOR reaction, no similar effects were observed. The AgNOR staining itself was not influenced by the staining sequence. The putative effect of additional ER staining on the number and area of AgNORs was investigated. A high correlation between the AgNOR number per nucleus in only AgNOR-stained and ER/AgNOR-stained nuclei was found (Fig. 2). Similar results were obtained by investigation of total AgNOR area (Fig. 3). Comparing AgNOR number per nucleus and total AgNOR area per nucleus in single AgNOR-stained and ER/AgNORstained nuclei no difference was found (Table 1). It is concluded that additional ER staining has no effect on AgNOR visualisation. Furthermore, it had to be determined if additional AgNOR staining influences ER positivity. In all five ER negative cases neither in the only ER-staining nor in the ER/AgNOR dual staining ER positive nuclei could be detected. It can be concluded that ER/AgNOR staining does not increase ER-staining intensity. The proof of independence of the ER-staining from the effects of AgNOR staining could be obtained by correlation of total number of ER-positive cells within 6 image sections (one image section equals 105 240 µm on the slide) in single ER-stained and ER/AgNOR-stained specimen (r = 0.942). Obviously, the same tumor cells are stained in single ER staining and ER/AgNOR staining. It can be deducted that the AgNOR reaction does not affect the ER-staining.

L. Günther and P. Hufnagl / Dual staining of estrogen receptors and AgNORs 153 Fig. 2. Correlation of the mean AgNOR number per nucleus in single AgNOR stained cells (NORNB AgNOR) and ER/AgNOR stained cells (NORNB ER/AgNOR). The circles represent 10 invasive ductal breast cancers (5 ER-positive and 5 ER-negative cases). Fig. 3. Correlation of the total AgNOR area per nucleus in single AgNOR stained cells (NORAREA AgNOR) and ER/AgNOR stained cells (NORAREA ER/AgNOR). The circles represent 10 invasive ductal breast cancers (5 ER-positive and 5 ER-negative cases). It could be proved that neither the ER staining affects the AgNOR visualisation nor the AgNOR method has any influence on the ER marking. 4. Discussion The fixing and embedding process has various consequences for the tissue. While there is a better histomorphological aspect compared to frozen sections, there is also a loss of sensitivity for immunohistochemical methods. The cause seems to be a change in the surface-structure of the epitopes. A similar process was found in the AgNOR staining procedure. Silver staining of paraffin sections is fundamentally weaker than those of frozen sections. Different studies describe approaches for the unmasking of alterated proteins by autoclaving. These methods were independently published for immunohistochemistry [2] as well as for Ag- NOR reaction [3]. Because antigen retrieval by autoclaving is necessary for both staining methods, this step was carried out only once at the beginning of the staining procedure.

154 L. Günther and P. Hufnagl / Dual staining of estrogen receptors and AgNORs Table 1 AgNOR number per nucleus (NORNB) and total AgNOR area per nucleus (NORAREA) [µm 2 ] in single AgNOR and ER/AgNOR stained slides Nr. AgNOR number per Difference AgNOR area per Difference nucleus (NORNB) nucleus (NORAREA) AgNOR- ER/AgNOR AgNOR- ER/AgNOR staining staining staining staining 1 1.83 1.55 0.28 4.93 5.00 0.07 2 1.72 1.65 0.07 5.80 5.66 0.14 3 2.51 2.93 0.42 5.73 7.33 1.60 4 3.63 3.62 0.01 5.93 5.53 0.40 5 1.45 1.11 0.34 1.06 0.80 0.26 6 2.39 2.92 0.53 9.66 10.86 1.20 7 2.94 2.99 0.05 10.53 10.68 0.15 8 2.27 1.84 0.43 7.26 7.00 0.26 9 2.36 2.33 0.03 6.20 6.40 0.20 10 3.22 3.46 0.24 5.93 6.66 0.73 mean 2.43 2.44 0.008 6.30 6.59 0.031 Munakata et al. [4] tried to establish a dual staining method for Ki-67/AgNORs. In dual stained cells total AgNOR area per nucleus was clearly higher. No significant difference was found in the AgNOR number. For unmasking Ki-67 proteins microwave radiation was used. This approach was used for Ki-67/AgNOR staining but not for only AgNOR-stained slides. It was concluded that microwave treatment affects the Ag- NOR staining. Today, it is known that any kind of antigen retrieval increases the sensitivity of the AgNOR method as well. Therefore autoclaving of the slides is part of the standard staining scheme today. When the same unmasking technique was used in a standardised scheme in dually stained slides as well as in individual AgNOR-marked slides, no differences regarding Ag- NOR number and area could be found. Lorenzato et al. [5] recently described a doublestaining technique for AgNORs and MIB-1 in breast cancer for measuring AgNORs in MIB-1-positive and - negative cells. The MIB-1 antibody was FITC-labelled in order to prevent thresholding and segmentation problems. Consequently, slides have to be stored at 20 C and have to be analysed within a short interval. However, in our method the staining result was permanently stable. Tomobe et al. [6] applied a dual-labelling technique for AgNORs and MIB-1 in superficial bladder tumors, but quantified both markers separately and correlated the results. We consider the outstanding feature of a double-staining method to provide insight in the connections between two markers on the cellular level. By simply correlating AgNOR counts and labelling indexes potentially useful information might be lost. In summary, it could be proved that there are no reciprocal affects of the single staining methods. The simultaneous staining of ER and AgNORs leads to a reproducible and specific staining result. We concluded that measuring AgNORs in immunhistochemically marked nuclei is methodologically justified. References [1] D. Öfner, M. Aubele, S. Biesterfeld et al., Guidelines of AgNOR quantitation: first update, Virchows Archiv 427 (1995), 341. [2] B. Bier, A. Bankfalvi, L. Grote, S. Blasius and D. Ofner, Wet autoclave pretreatment for immunhistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue, Histochem. J. 27 (1995), 148 154. [3] D. Öfner, A. Bankfalvi, K. Riehemann, B. Bier, W. Bocker and K.W. Schmidt, Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues, Mod. Pathol. 7 (1994), 946 950. [4] S. Munakata and J.B. Hendricks, A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue, J. Histochem. Cytochem. 42 (1994), 789 793. [5] M. Lorenzato, P. Abboud, C. Lechki, F. Browarnyi, M.F.O. O Donohue, D. Ploton and J.J. Adnet, Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry, Micron 31 (2000), 151 159. [6] M. Tomobe, T. Shimazui, K. Uchida, S. Hinotsu and H. Akaza, Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor, J. Urol. 162 (1999), 63 68.

MEDIATORS of INFLAMMATION The Scientific World Journal Gastroenterology Research and Practice Diabetes Research International Endocrinology Immunology Research Disease Markers Submit your manuscripts at BioMed Research International PPAR Research Obesity Ophthalmology Evidence-Based Complementary and Alternative Medicine Stem Cells International Oncology Parkinson s Disease Computational and Mathematical Methods in Medicine AIDS Behavioural Neurology Research and Treatment Oxidative Medicine and Cellular Longevity